Rationale for Once-Daily or Twice-Daily Dosing of Zanubrutinib in Patients with Mantle Cell Lymphoma.
Leukemia & lymphoma/Leukemia and lymphoma（2021）
Key words
Bruton's tyrosine kinase inhibitors,dosing regimens,exposure-response analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined